Article | Published:

CD4 downregulation by memory CD4+ T cells in vivo renders African green monkeys resistant to progressive SIVagm infection

Nature Medicine volume 15, pages 879885 (2009) | Download Citation

Abstract

African green monkeys (genus Chlorocebus) can be infected with species-specific simian immunodeficiency virus (SIVagm) but do not develop AIDS. These natural hosts of SIV, like sooty mangabeys, maintain high levels of SIV replication but have evolved to avoid immunodeficiency. Elucidating the mechanisms that allow natural hosts to coexist with SIV without overt disease may provide crucial information for understanding AIDS pathogenesis. Here we show that many CD4+ T cells from African green monkeys downregulate CD4 in vivo as they enter the memory pool; that downregulation of CD4 by memory T cells is independent of SIV infection; that the CD4 memory T cells maintain functions that are normally attributed to CD4+ T cells, including production of interleukin-2 (IL-2), production of IL-17, expression of forkhead box P3 and expression of CD40 ligand; that loss of CD4 expression protects these T cells from infection by SIVagm in vivo; and that these CD4 T cells can maintain major histocompatibility complex class II restriction. These data show that the absence of SIV-induced disease progression in natural host species may be partially explained by preservation of a subset of T cells that maintain CD4+ T cell function while being resistant to SIV infection in vivo.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , , & AIDS as a zoonosis: scientific and public health implications. Science 287, 607–614 (2000).

  2. 2.

    , & Nonpathogenic CCR2-tropic SIVrcm after serial passage and its effect on SIVmac infection of Indian rhesus macaques. Virology 379, 38–44 (2008).

  3. 3.

    et al. Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells. J. Virol. 74, 6893–6910 (2000).

  4. 4.

    et al. Characterization of novel simian immunodeficiency viruses from red-capped mangabeys from Nigeria (SIVrcmNG409 and -NG411). J. Virol. 75, 12014–12027 (2001).

  5. 5.

    , , & Into the wild: simian immunodeficiency virus (SIV) infection in natural hosts. Trends Immunol. 29, 419–428 (2008).

  6. 6.

    , , , & Understanding the benign nature of SIV infection in natural hosts. J. Clin. Invest. 117, 3148–3154 (2007).

  7. 7.

    What can natural infection of African monkeys with simian immunodeficiency virus tell us about the pathogenesis of AIDS? AIDS Rev. 6, 40–53 (2004).

  8. 8.

    et al. Comparison of simian immunodeficiency virus SIVagmVer replication and CD4+ T cell dynamics in vervet and sabaeus African green monkeys. J. Virol. 80, 4868–4877 (2006).

  9. 9.

    et al. Simian immunodeficiency virus SIVagm.sab infection of Caribbean African green monkeys: a new model for the study of SIV pathogenesis in natural hosts. J. Virol. 80, 4858–4867 (2006).

  10. 10.

    et al. Wide range of viral load in healthy African green monkeys naturally infected with simian immunodeficiency virus. J. Virol. 74, 11744–11753 (2000).

  11. 11.

    et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18, 441–452 (2003).

  12. 12.

    et al. Simian immunodeficiency viruses replication dynamics in African non-human primate hosts: common patterns and species-specific differences. J. Med. Primatol. 35, 194–201 (2006).

  13. 13.

    et al. Depletion of CD8+ cells in sooty mangabey monkeys naturally infected with simian immunodeficiency virus reveals limited role for immune control of virus replication in a natural host species. J. Immunol. 178, 8002–8012 (2007).

  14. 14.

    et al. The AIDS resistance of naturally SIV-infected sooty mangabeys is independent of cellular immunity to the virus. Blood 108, 209–217 (2006).

  15. 15.

    et al. Availability of activated CD4+ T cells dictates the level of viremia in naturally SIV-infected sooty mangabeys. J. Clin. Invest. 118, 2039–2049 (2008).

  16. 16.

    et al. Paucity of CD4+ CCR5+ T cells may prevent transmission of simian immunodeficiency virus in natural nonhuman primate hosts by breast-feeding. J. Virol. 82, 5501–5509 (2008).

  17. 17.

    et al. Short-lived infected cells support virus replication in sooty mangabeys naturally infected with simian immunodeficiency virus: implications for AIDS pathogenesis. J. Virol. 82, 3725–3735 (2008).

  18. 18.

    et al. Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication. J. Virol. 69, 955–967 (1995).

  19. 19.

    et al. Plateau levels of viremia correlate with the degree of CD4+-T-cell loss in simian immunodeficiency virus SIVagm-infected pigtailed macaques: variable pathogenicity of natural SIVagm isolates. J. Virol. 79, 5153–5162 (2005).

  20. 20.

    et al. Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival. J. Virol. 71, 284–290 (1997).

  21. 21.

    et al. A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543–3. J. Virol. 71, 1608–1620 (1997).

  22. 22.

    et al. Complete nucleotide sequence, genome organization and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation. J. Virol. 66, 6587–6600 (1992).

  23. 23.

    , , & Identification and biologic characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIV/SMM). AIDS Res. Hum. Retroviruses 5, 397–409 (1989).

  24. 24.

    et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 179, 859–870 (1999).

  25. 25.

    et al. Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection. J. Virol. 74, 1209–1223 (2000).

  26. 26.

    et al. Correlates of preserved CD4+ T-cell homeostasis during natural, nonpathogenic simian immunodeficiency virus infection of sooty mangabeys: implications for AIDS pathogenesis. J. Immunol. 178, 1680–1691 (2007).

  27. 27.

    et al. High levels of SIVmnd-1 replication in chronically infected Mandrillus sphinx. Virology 317, 119–127 (2003).

  28. 28.

    et al. Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence. J. Immunol. 179, 3035–3046 (2007).

  29. 29.

    , , & An African green monkey lacking peripheral CD4 lymphocytes that retains helper T-cell activity and coexists with SIVagm. Clin. Exp. Immunol. 117, 504–512 (1999).

  30. 30.

    et al. CD4 and CD8 expressions in African green monkey helper T lymphocytes: implication for resistance to SIV infection. Int. Immunol. 9, 843–851 (1997).

  31. 31.

    et al. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12, 881–922 (1994).

  32. 32.

    et al. Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells. Br. J. Haematol. 126, 81–84 (2004).

  33. 33.

    et al. HIV-1–specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat. Med. 5, 518–525 (1999).

  34. 34.

    et al. T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis. J. Virol. 78, 1160–1168 (2004).

  35. 35.

    et al. Differential TH17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 112, 2826–2835 (2008).

  36. 36.

    et al. Severe depletion of mucosal CD4+ T cells in AIDS-free simian immunodeficiency virus–infected sooty mangabeys. J. Immunol. 179, 3026–3034 (2007).

  37. 37.

    et al. Paucity of CD4+CCR5+ T cells is a typical feature of natural SIV hosts. Blood 109, 1069–1076 (2007).

  38. 38.

    et al. Relationship between T-cell activation and CD4+ T-cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J. Infect. Dis. 197, 126–133 (2008).

  39. 39.

    et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J. Infect. Dis. 199, 1177–1185 (2009).

  40. 40.

    et al. Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1–infected patients. AIDS 23, 369–375 (2009).

  41. 41.

    et al. Elevated plasma lipopolysaccharide is not sufficient to drive natural killer cell activation in HIV-1–infected individuals. AIDS 23, 29–34 (2009).

  42. 42.

    et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12, 1365–1371 (2006).

  43. 43.

    et al. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One 3, e2516 (2008).

  44. 44.

    et al. Human immunodeficiency virus–related microbial translocation and progression of hepatitis C. Gastroenterology 135, 226–233 (2008).

  45. 45.

    et al. Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. AIDS 22, 2035–2038 (2008).

  46. 46.

    , , & Immunophenotypic patterns of CD8+ T-cell subsets expressing CD8αα and IL-7Rα in viremic, aviremic and slow progressor HIV-1–infected subjects. Clin. Immunol. 124, 149–157 (2007).

  47. 47.

    et al. Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4. Nature 353, 180–184 (1991).

  48. 48.

    et al. Class II major histocompatibility complex–restricted T-cell function in CD4-deficient mice. Eur. J. Immunol. 24, 2213–2218 (1994).

  49. 49.

    , , , & The CD4 and CD8 antigens are coupled to a protein-tyrosine kinase (p56lck) that phosphorylates the CD3 complex. Proc. Natl. Acad. Sci. USA 86, 3277–3281 (1989).

  50. 50.

    , , , & Sequence and functional properties of African green monkey CD4 silencer. Immunol. Lett. 75, 47–53 (2000).

  51. 51.

    & Chromatin and CD4, CD8A and CD8B gene expression during thymic differentiation. Nat. Rev. Immunol. 2, 909–919 (2002).

  52. 52.

    et al. Negative regulation of CD8 expression via Cd8 enhancer–mediated recruitment of the zinc finger protein MAZR. Nat. Immunol. 7, 392–400 (2006).

  53. 53.

    et al. Virally induced CD4+ T-cell depletion is not sufficient to induce AIDS in a natural host. J. Immunol. 179, 3047–3056 (2007).

  54. 54.

    et al. T-lymphocyte profiles in FIV-infected wild lions and pumas reveal CD4 depletion. J. Wildl. Dis. 42, 234–248 (2006).

  55. 55.

    et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434, 1093–1097 (2005).

Download references

Acknowledgements

These studies were supported by the intramural National Institute of Allergy and Infectious Diseases, US National Institutes of Health program and by R01 AI064066 (I.P.), R01 AI065325 (C.A.) and RR-00168 (Tulane National Primate Center). We would like to thank the Bad Boys of Cleveland, D. Douek (Vaccine Research Center, National Institute of Allergy and Infectious Diseases, US National Institutes of Health) and D. Price (Cardiff University) for helpful discussions. We are grateful to J.E. Schmitz and R. Zahn (Harvard University) for the kind donation of microbeads coated with antibody to CD3 and CD28 for stimulation of T cells from nonhuman primates. We also appreciate the technical advice of B. Lafont and G. Mettler.

Author information

Affiliations

  1. Lab of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland, USA.

    • Coreen M Beaumier
    • , Levelle D Harris
    • , Simoy Goldstein
    • , Nichole R Klatt
    • , Sonya Whitted
    • , John McGinty
    • , Vanessa M Hirsch
    •  & Jason M Brenchley
  2. Divisions of Comparative Pathology and Microbiology, Tulane National Primate Center, New Orleans, Louisiana, USA.

    • Cristian Apetrei
    •  & Ivona Pandrea

Authors

  1. Search for Coreen M Beaumier in:

  2. Search for Levelle D Harris in:

  3. Search for Simoy Goldstein in:

  4. Search for Nichole R Klatt in:

  5. Search for Sonya Whitted in:

  6. Search for John McGinty in:

  7. Search for Cristian Apetrei in:

  8. Search for Ivona Pandrea in:

  9. Search for Vanessa M Hirsch in:

  10. Search for Jason M Brenchley in:

Contributions

C.M.B., L.D.H., N.R.K., S.W., J.M. and J.M.B. performed experiments and analyzed the data. S.G., C.A., I.P. and V.M.H. provided specimens and analyzed data. All authors contributed to the project's planning and writing of the manuscript. J.M.B. supervised the project.

Corresponding author

Correspondence to Jason M Brenchley.

Supplementary information

PDF files

  1. 1.

    Supplementary Text and Figures

    Supplementary Figs. 1–3

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nm.1970

Further reading